Infectious Complications Associated with Immunomodulating Biologic Agents
Authors:
- Sophia KooSKSophia Koo
- Francisco M. MartyFMFrancisco M. Marty
- Lindsey R. BadenLBLindsey R. Baden
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 24 (2) , 285-306
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α InhibitorsClinical Infectious Diseases, 2009
- Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?Clinical Rheumatology, 2009
- Nocardiosis in a renal transplant recipient following rituximab preconditioningUpsala Journal of Medical Sciences, 2009
- Persistent and Relapsing Babesiosis in Immunocompromised PatientsClinical Infectious Diseases, 2008
- Aspergillus infection in lung transplant patients: incidence and prognosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studiesArthritis & Rheumatism, 2007
- Cerebral nocardiosis in a patient with NHL treated with rituximabAmerican Journal of Hematology, 2007
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized studyJournal of the American Academy of Dermatology, 2003
- Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximabAmerican Journal of Hematology, 2001